155 related articles for article (PubMed ID: 27121919)
1. Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation.
Ostasiewicz B; Ostasiewicz P; Duś-Szachniewicz K; Ostasiewicz K; Ziółkowski P
Mol Med Rep; 2016 Jun; 13(6):5084-92. PubMed ID: 27121919
[TBL] [Abstract][Full Text] [Related]
2. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
3. Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.
Lauriola M; Ugolini G; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Rivetti S; Mattei G; Coppola D; Strippoli P; Taffurelli M; Solmi R
Int J Oncol; 2010 Aug; 37(2):519-25. PubMed ID: 20596680
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
5. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
6. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.
Li M; Peng F; Li G; Fu Y; Huang Y; Chen Z; Chen Y
Oncotarget; 2016 Jun; 7(24):37226-37237. PubMed ID: 27191989
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
9. [Differential expression of secretagogin and glucose-related protein 78 in colorectal carcinoma: a proteome study].
Xing XM; Wang YH; Huang Q; Lü BJ; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):107-12. PubMed ID: 17493385
[TBL] [Abstract][Full Text] [Related]
10. Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma.
Kunicka T; Prochazka P; Krus I; Bendova P; Protivova M; Susova S; Hlavac V; Liska V; Novak P; Schneiderova M; Pitule P; Bruha J; Vycital O; Vodicka P; Soucek P
BMC Cancer; 2016 Oct; 16(1):795. PubMed ID: 27733154
[TBL] [Abstract][Full Text] [Related]
11. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
13. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
[TBL] [Abstract][Full Text] [Related]
15. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
16. SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
López-Sánchez LM; Jiménez-Izquierdo R; Peñarando J; Mena R; Guil-Luna S; Toledano M; Conde F; Villar C; Díaz C; Ortea I; De la Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
J Cell Mol Med; 2019 Dec; 23(12):8219-8232. PubMed ID: 31560832
[TBL] [Abstract][Full Text] [Related]
17. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer.
Weng W; Liu N; Toiyama Y; Kusunoki M; Nagasaka T; Fujiwara T; Wei Q; Qin H; Lin H; Ma Y; Goel A
Mol Cancer; 2018 Jan; 17(1):16. PubMed ID: 29382334
[TBL] [Abstract][Full Text] [Related]
18. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
19. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
Kume H; Muraoka S; Kuga T; Adachi J; Narumi R; Watanabe S; Kuwano M; Kodera Y; Matsushita K; Fukuoka J; Masuda T; Ishihama Y; Matsubara H; Nomura F; Tomonaga T
Mol Cell Proteomics; 2014 Jun; 13(6):1471-84. PubMed ID: 24687888
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
